Bridge-building cancer research partnership for education, outreach, and science
Official title: The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research
Funded at Dana-Farber Cancer Inst · NIH-11564030 · Data updated 2026-11-12
A joint effort between UMass Boston and Harvard Cancer Consortium to accelerate cancer research and education by connecting lower-resourced institutions with a leading cancer center.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 27, 2010 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $569,882 |
| NIH project number | 3U54CA156732-15S2 |
| Project ID | NIH-11564030 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include students, trainees, and community groups in areas with high cancer risk who can participate in educational and research activities and benefit from enhanced translational opportunities.
✕Less likely to help
The grant itself does not describe a specific patient intervention; individuals seeking direct treatment in a trial may not be the primary focus here.
What this research studies
This project creates a collaboration between UMass Boston and the Harvard Cancer Consortium to close gaps in cancer science and education. It focuses on transdisciplinary research, workforce development, and outreach to communities at high risk for cancer. The effort aims to integrate biology, population science, and education across multiple cores and projects to accelerate translation. It emphasizes training students and trainees and building capacity for cancer research in diverse settings. The initiative showcases a model for bridging divides in research and practice at state and national levels.
Why it matters
Potential benefit: If successful, it could strengthen cancer research and education in under-resourced areas, leading to improved prevention, detection, and care pathways for diverse populations.
How similar studies have gone: This model has been used to bridge institutional divides and improve capacity, with varying levels of success depending on implementation and resources.
Where this research is happening
-
Dana-Farber Cancer Inst
Boston, United States Active
Researchers
- Principal investigator: Abel, Gregory Alan — Dana-Farber Cancer Inst
- Study coordinator: Abel, Gregory Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.